CORBUS PHARMACEUTICALS HOLDI (CRBP)
US21833P3010 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to CRBP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 64.26. This target is 243.27% above the current price.
CRBP was analyzed by 14 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CRBP.
In the previous month the buy percentage consensus was at a similar level.
CRBP was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-20 | Mizuho | Reiterate | Outperform -> Outperform |
| 2024-09-20 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-09-20 | B. Riley Securities | Maintains | Buy -> Buy |
| 2024-09-20 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-08-28 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-07 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-22 | HC Wainwright & Co. | Reiterate | Buy |
| 2024-07-10 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-06-26 | B. Riley Securities | Initiate | Buy |
| 2024-06-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-06-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-13 | RBC Capital | Initiate | Outperform |
| 2024-05-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-03-13 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-06 | Jefferies | Upgrade | Hold -> Buy |
| 2024-01-29 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-09 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-05-10 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2023-03-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-14 | HC Wainwright & Co. | Reiterate | Buy |